Moderna Inc. buy Royal Bank of Canada
Start price
23.02.24
/
50%
€89.00
Target price
23.02.25
€115.45
Performance (%)
-62.03%
End price
24.02.25
€33.79
Summary
This prediction ended on 24.02.25 with a price of €33.79. The BUY prediction by Royal_Bank_of_Canada for Moderna Inc. performed very badly with a performance of -62.03%. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Moderna Inc. | 4.774% | 4.774% | -33.132% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Moderna Inc. diskutieren
Moderna, Inc. (NASDAQ: MRNA) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $125.00 price target on the stock.
Ratings data for MRNA provided by MarketBeat
In the thread Trading Moderna Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten